{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:55:09Z","timestamp":1791471309404,"version":"4.3.4"},"reference-count":24,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2004,8,15]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To determine whether adding regular acetaminophen (paracetamol) could improve pain and well-being in people with advanced cancer and pain despite strong opioids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>Participants took acetaminophen for 48 hours and placebo for 48 hours. The order (acetaminophen or placebo first) was randomly allocated. Pain was the primary outcome. Preferences, number of opioid breakthrough doses, overall well-being, nausea and vomiting, drowsiness, constipation, and cold sweats were secondary outcomes. Patients rated themselves daily with visual analog scales (VAS) and a verbal numeric scale (VNS) for pain, all scaled from 0 to 10.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty patients completed the trial. The oral opioid was morphine in 23 patients and hydromorphone in seven patients. The median daily opioid dose in oral morphine equivalents was 200 mg (range, 20 to 2,100 mg). Nonsteroidal anti-inflammatory drugs, corticosteroids, or both were used by 16 patients. Pain and overall well-being were better for patients receiving acetaminophen than for those receiving placebo. The mean difference was 0.4 (95% CI, 0.1 to 0.8; P = .03) in VNS for pain, 0.6 (95% CI, \u22120.1 to 1.3; P = .09) in VAS for pain, and 0.7 (95% CI, 0.0 to 1.4; P = .05) in VAS for overall well-being. More patients preferred the period they took acetaminophen (n = 14) than the period they took placebo (n = 8), but many had no preference (n = 8). There were no differences in the other outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Acetaminophen improved pain and well-being without major side effects in patients with cancer and persistent pain despite a strong opioid regimen. Its addition is worth considering in all such patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/jco.2004.09.122","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T04:37:26Z","timestamp":1092458246000},"page":"3389-3394","source":"Crossref","is-referenced-by-count":97,"title":["Acetaminophen (Paracetamol) Improves Pain and Well-Being in People With Advanced Cancer Already Receiving a Strong Opioid Regimen: A Randomized, Double-Blind, Placebo-Controlled Cross-Over Trial"],"prefix":"10.1200","volume":"22","author":[{"given":"Martin","family":"Stockler","sequence":"first","affiliation":[{"name":"From the Department of Medicine and School of Public Health, and NHMRC Clinical Trials Centre, University of Sydney, Camperdown; Sydney Cancer Centre, Concord Repatriation General Hospital, Concord, Australia; and Princess Margaret Hospital, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janette","family":"Vardy","sequence":"additional","affiliation":[{"name":"From the Department of Medicine and School of Public Health, and NHMRC Clinical Trials Centre, University of Sydney, Camperdown; Sydney Cancer Centre, Concord Repatriation General Hospital, Concord, Australia; and Princess Margaret Hospital, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinesh","family":"Pillai","sequence":"additional","affiliation":[{"name":"From the Department of Medicine and School of Public Health, and NHMRC Clinical Trials Centre, University of Sydney, Camperdown; Sydney Cancer Centre, Concord Repatriation General Hospital, Concord, Australia; and Princess Margaret Hospital, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Warr","sequence":"additional","affiliation":[{"name":"From the Department of Medicine and School of Public Health, and NHMRC Clinical Trials Centre, University of Sydney, Camperdown; Sydney Cancer Centre, Concord Repatriation General Hospital, Concord, Australia; and Princess Margaret Hospital, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198507113130205"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403033300902"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04515-3"},{"key":"R4","unstructured":"World Health Organisation. Cancer Pain Relief . Geneva, Switzerland, World Health Organisation, 1986"},{"key":"R5","unstructured":"St Jerhsward J: WHO cancer pain relief programme. Cancer Surv 7:195,1988-208,"},{"key":"R6","unstructured":"World Health Organisation. Palliative Cancer Care: Pain Relief and Management of Other Symptoms . Geneva, Switzerland, World Health Organisation Publications Centre, 1992"},{"key":"R7","unstructured":"Twycross RG, Lack SA: Symptom Control in Terminal Cancer (ed 2) . Edinburgh, Scotland, Churchill Livingstone, 1990"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199107113250203"},{"key":"R9","unstructured":"Doyle D, Hanks GWC, MacDonald N Oxford Textbook of Palliative Medicine . Oxford, United Kingdom, Oxford University Press, 1993"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1983.14"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7053.321"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Curatolo M, Sveticic G: Drug combinations in pain treatment: A review of the published evidence and a method for finding the optimal combination. Best Pract Res Clin Anaesthesiol 16:507,2002-519,","DOI":"10.1053\/bean.2002.0254"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1053\/bean.2002.0262"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1979.tb05903.x"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(89)90005-6"},{"key":"R16","unstructured":"Wells GA, Tugwell P, Kraag GR, et al: Minimum important difference between patients with rheumatoid arthritis: The pa-tient's perspective. J Rheumatol 20:557,1993-560,"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1987.211"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1984.tb01810.x"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Schug S, Sidebotham D, McGuinnety M, et al: Acetaminophen as an adjunct to morphine by patient-controlled analgesia in the management of acute postoperative pain. Anesth Analg 87:368,1998-372,","DOI":"10.1097\/00000539-199808000-00024"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/83.2.253"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199908000-00019"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(95)00004-I"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-200106000-00024"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1998.tb04919.x"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2004.09.122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T16:55:43Z","timestamp":1653497743000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2004.09.122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,15]]},"references-count":24,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2004,8,15]]}},"alternative-id":["10.1200\/JCO.2004.09.122"],"URL":"https:\/\/doi.org\/10.1200\/jco.2004.09.122","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1049309.501219","asserted-by":"object"}]},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,15]]}}}